We are live on ! Find out more
OPRX icon

OptimizeRx
OPRX

142 hedge funds and large institutions have $760M invested in OptimizeRx in 2021 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 45 increasing their positions, 40 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 18

114% more call options, than puts

Call options by funds: $55.2M | Put options by funds: $25.8M

34% more capital invested

Capital invested by funds: $567M → $760M (+$192M)

17% more funds holding

Funds holding: 121 → 142 (+21)

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

13% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 40

2.18% more ownership

Funds ownership: 68.96% → 71.14% (+2.2%)

Holders
142
Holders Change
+21
Holders Change %
+17.36%
% of All Funds
2.47%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.12%
New
39
Increased
45
Reduced
40
Closed
18
Calls
$55.2M
Puts
$25.8M
Net Calls
+$29.4M
Net Calls Change
-$4.32M

Top Buyers

1
PCA
Prospect Capital Advisors
California
+$15.6M
2
DCM
Driehaus Capital Management
Illinois
+$6.18M
3
LCG
Lisanti Capital Growth
New York
+$5.21M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.39M
5
FLAM
First Light Asset Management
Minnesota
+$3.59M

Top Sellers

1
MS
Maven Securities
Jersey
-$5.73M
2
Marshall Wace
Marshall Wace
United Kingdom
-$5.11M
3
Two Sigma Investments
Two Sigma Investments
New York
-$3.84M
4
GIPM
G2 Investment Partners Management
New York
-$3.02M
5
NCGI
Next Century Growth Investors
Minnesota
-$2.11M
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
26
Driehaus Capital Management
Illinois
$7.51M +$6.18M +121,366 New
SAM
27
Silvercrest Asset Management
New York
$7.44M -$17.1K -337 -0.3%
PCM
28
Perkins Capital Management
Minnesota
$7.21M -$268K -5,276 -4%
HI
29
Handelsinvest Investeringsforvaltning
Denmark
$6.81M – – –
LCG
30
Lisanti Capital Growth
New York
$6.34M +$5.21M +102,351 New
Mirae Asset Global Investments
31
Mirae Asset Global Investments
South Korea
$5.77M -$930K -18,269 -16%
Calamos Advisors
32
Calamos Advisors
Illinois
$5.29M -$706K -13,877 -14%
HIM
33
Hillsdale Investment Management
Ontario, Canada
$5.29M -$509K -10,000 -10%
Swedbank
34
Swedbank
Sweden
$4.95M -$254K -5,000 -6%
SST
35
S Squared Technology
New York
$4.7M -$292K -5,744 -7%
Goldman Sachs
36
Goldman Sachs
New York
$4.06M -$1.2M -23,527 -26%
N
37
Nuveen
North Carolina
$3.96M -$342K -6,712 -9%
Bank of America
38
Bank of America
North Carolina
$3.58M -$516K -10,142 -15%
Russell Investments Group
39
Russell Investments Group
United Kingdom
$3.45M -$1.08M -21,224 -28%
PGM
40
Parian Global Management
New York
$3.14M +$2.58M +50,774 New
Bank of New York Mellon
41
Bank of New York Mellon
New York
$2.82M +$135K +2,651 +6%
RHJA
42
Rice Hall James & Associates
California
$2.79M +$2.29M +44,985 New
PPA
43
Parametric Portfolio Associates
Washington
$2.71M +$319K +6,264 +17%
EI
44
EAM Investors
California
$2.71M – – –
Morgan Stanley
45
Morgan Stanley
New York
$2.51M +$1.54M +30,259 +293%
Charles Schwab
46
Charles Schwab
California
$2.5M +$37.1K +730 +2%
ACA
47
Apis Capital Advisors
New York
$2.48M +$509K +10,000 +33%
Wells Fargo
48
Wells Fargo
California
$2.43M -$66.2K -1,300 -3%
EIM
49
Essex Investment Management
Massachusetts
$2.36M +$601K +11,807 +45%
MS
50
Maven Securities
Jersey
$2.28M -$5.73M -112,500 -75%
1
2
3 4 5

OPRX Hedge Fund Activity: Q2 2021 in Review

142 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q2 2021, worth a combined $760M — up 34% from $567M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new OPRX positions and 18 closed out — a net gain of 21 holders — while 45 added to existing stakes and 40 trimmed.

The largest buyer was Prospect Capital Advisors, opening a new position worth an estimated $15.6M. The largest seller was Maven Securities, cutting an estimated $5.73M.

  • 142 institutional investors held OptimizeRx (OPRX) as of Q2 2021, up from 121 in Q1 2021.
  • Funds reported $760M of OptimizeRx stock for Q2 2021, up 34% quarter-over-quarter.
  • 39 funds opened new OptimizeRx positions in Q2 2021 and 18 closed out, a net change of +21 holders.
  • The largest OptimizeRx buyer in Q2 2021 was Prospect Capital Advisors, an estimated $15.6M added.
  • The largest OptimizeRx seller in Q2 2021 was Maven Securities, an estimated $5.73M sold.

Based on aggregated 13F filings for Q2 2021.